Ratio de margen de beneficio operativo
desde 2005

Bajo nivel de dificultad

Abbott Laboratories, ratio de margen de beneficio operativo, tendencias a largo plazo, cálculo

	Ratio de margen de beneficio operativo	=	100	×	Ganancias operativas¹	÷	Las ventas netas¹
31 dic. 2020	15.48%	=	100	×	5,357	÷	34,608
31 dic. 2019	14.21%	=	100	×	4,532	÷	31,904
31 dic. 2018	11.94%	=	100	×	3,650	÷	30,578
31 dic. 2017	6.30%	=	100	×	1,726	÷	27,390
31 dic. 2016	15.27%	=	100	×	3,185	÷	20,853
31 dic. 2015	14.05%	=	100	×	2,867	÷	20,405
31 dic. 2014	12.84%	=	100	×	2,599	÷	20,247
31 dic. 2013	12.03%	=	100	×	2,629	÷	21,848
31 dic. 2012	20.28%	=	100	×	8,085	÷	39,874
31 dic. 2011	14.81%	=	100	×	5,752	÷	38,851
31 dic. 2010	17.31%	=	100	×	6,088	÷	35,167
31 dic. 2009	20.27%	=	100	×	6,236	÷	30,765
31 dic. 2008	19.28%	=	100	×	5,694	÷	29,528
31 dic. 2007	17.67%	=	100	×	4,579	÷	25,914
31 dic. 2006	9.09%	=	100	×	2,042	÷	22,476
31 dic. 2005	19.53%	=	100	×	4,362	÷	22,338

¹ US $ en millones

Abbott Laboratories, ratio de margen de beneficio operativo, tendencias a largo plazo, comparación con la competencia

	Abbott Laboratories	AbbVie Inc.	Amgen Inc.	Gilead Sciences Inc.	Illumina Inc.	Regeneron Pharmaceuticals Inc.	Vertex Pharmaceuticals Inc.
31 dic. 2020	15.48%	24.81%	37.70%	—	17.91%	42.09%	46.03%
31 dic. 2019	14.21%	39.03%	43.57%	19.38%	27.80%	28.10%	28.77%
31 dic. 2018	11.94%	19.49%	45.55%	37.83%	26.49%	37.77%	20.84%
31 dic. 2017	6.30%	33.99%	45.76%	55.04%	22.02%	35.41%	4.95%
31 dic. 2016	15.27%	36.60%	44.74%	58.87%	24.48%	27.38%	0.58%
31 dic. 2015	14.05%	32.97%	40.44%	69.03%	27.61%	30.51%	-45.23%
31 dic. 2014	12.84%	17.09%	32.03%	62.37%	27.65%	29.74%	-119.30%
31 dic. 2013	12.03%	30.14%	32.25%	41.87%	9.44%	36.11%	-74.54%
31 dic. 2012	20.28%	31.65%	33.52%	42.67%	17.48%	33.20%	0.15%
31 dic. 2011	14.81%	—	28.19%	46.77%	18.90%	-46.02%	8.07%
31 dic. 2010	17.31%	—	37.82%	53.62%	23.45%	-21.23%	-485.51%
31 dic. 2009	20.27%	—	38.37%	54.55%	18.85%	-19.54%	-602.63%
31 dic. 2008	19.28%	—	35.50%	52.68%	14.04%	-37.67%	-263.65%
31 dic. 2007	17.67%	—	27.81%	57.98%	-82.12%	-91.55%	-210.94%
31 dic. 2006	9.09%	—	27.71%	-29.32%	20.48%	-169.68%	-105.86%
31 dic. 2005	19.53%	—	40.33%	61.41%	-29.18%	-187.97%	-93.15%

Abbott Laboratories (NYSE:ABT)